Literature DB >> 31455888

Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies.

NaNa Keum1,2, Edward Giovannucci3,4,5,6.   

Abstract

Globally, colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the second leading cause of cancer death. Arising through three major pathways, including adenoma-carcinoma sequence, serrated pathway and inflammatory pathway, CRC represents an aetiologically heterogeneous disease according to subtyping by tumour anatomical location or global molecular alterations. Genetic factors such as germline MLH1 and APC mutations have an aetiologic role, predisposing individuals to CRC. Yet, the majority of CRC is sporadic and largely attributable to the constellation of modifiable environmental risk factors characterizing westernization (for example, obesity, physical inactivity, poor diets, alcohol drinking and smoking). As such, the burden of CRC is shifting towards low-income and middle-income countries as they become westernized. Furthermore, the rising incidence of CRC at younger ages (before age 50 years) is an emerging trend. This Review provides a comprehensive summary of CRC epidemiology, with emphasis on modifiable lifestyle and nutritional factors, chemoprevention and screening. Overall, the optimal reduction of CRC incidence and mortality will require concerted efforts to reduce modifiable risk factors, to leverage chemoprevention research and to promote population-wide and targeted screening.

Entities:  

Year:  2019        PMID: 31455888     DOI: 10.1038/s41575-019-0189-8

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  428 in total

1.  Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.

Authors:  Yan Zhang; Yuan Wu; Zi-Ying Gong; Hai-Dan Ye; Xiao-Kai Zhao; Jie-Yi Li; Xiao-Mei Zhang; Sheng Li; Wei Zhu; Mei Wang; Ge-Yu Liang; Yun Liu; Xin Guan; Dao-Yun Zhang; Bo Shen
Journal:  Curr Med Sci       Date:  2021-04-20

2.  MUC1-C drives stemness in progression of colitis to colorectal cancer.

Authors:  Wei Li; Ning Zhang; Caining Jin; Mark D Long; Hasan Rajabi; Yota Yasumizu; Atsushi Fushimi; Nami Yamashita; Masayuki Hagiwara; Rongbin Zheng; Jin Wang; Ling Kui; Harpal Singh; Surender Kharbanda; Qiang Hu; Song Liu; Donald Kufe
Journal:  JCI Insight       Date:  2020-06-18

Review 3.  Comprehensive review of targeted therapy for colorectal cancer.

Authors:  Yuan-Hong Xie; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Signal Transduct Target Ther       Date:  2020-03-20

4.  Switching off DNA repair-how colorectal cancer evades targeted therapies through adaptive mutability.

Authors:  Jörg Fahrer
Journal:  Signal Transduct Target Ther       Date:  2020-02-21

5.  Multivariate Investigation of Toxic and Essential Metals in the Serum from Various Types and Stages of Colorectal Cancer Patients.

Authors:  Mian H R Mahmood; Muhammad Abdul Qayyum; Farhan Yaseen; Tahir Farooq; Zahid Farooq; Muhammad Yaseen; Ahmad Irfan; Khawaja Muddassir; Muhammad Nadeem Zafar; Muhammad Tariq Qamar; Arshad Mehmood Abbasi; Hai-Yang Liu
Journal:  Biol Trace Elem Res       Date:  2021-02-26       Impact factor: 3.738

Review 6.  Host-microbiota maladaptation in colorectal cancer.

Authors:  Alina Janney; Fiona Powrie; Elizabeth H Mann
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

7.  Yogurt consumption and colorectal cancer incidence and mortality in the Nurses' Health Study and the Health Professionals Follow-Up Study.

Authors:  Karin B Michels; Walter C Willett; Rita Vaidya; Xuehong Zhang; Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2020-12-10       Impact factor: 7.045

8.  Synergistic antitumor effect of 5-fluorouracil and withaferin-A induces endoplasmic reticulum stress-mediated autophagy and apoptosis in colorectal cancer cells.

Authors:  Abdullah M Alnuqaydan; Bilal Rah; Abdulmajeed G Almutary; Shailender Singh Chauhan
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

9.  LAMB3 promotes tumour progression through the AKT-FOXO3/4 axis and is transcriptionally regulated by the BRD2/acetylated ELK4 complex in colorectal cancer.

Authors:  Zhehui Zhu; Jinglue Song; Yuegui Guo; Zhenyu Huang; Xiaojian Chen; Xuening Dang; Yuji Huang; Yuhan Wang; Weijun Ou; Yili Yang; Wei Yu; Chen-Ying Liu; Long Cui
Journal:  Oncogene       Date:  2020-05-12       Impact factor: 9.867

10.  Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.

Authors:  Hengyang Shen; Yixuan Meng; Tao Hu; Shuwei Li; Mulong Du; Junyi Xin; Dongying Gu; Meilin Wang; Zan Fu
Journal:  Arch Toxicol       Date:  2020-10-03       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.